Astrana Health (ASTH) Cash & Current Investments (2010 - 2026)

Astrana Health has reported Cash & Current Investments for 17 years, with the latest figure at $478.4 million in Q1 2026.

• Quarterly Cash & Current Investments rose 83.35% year-over-year to $478.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $478.4 million (up 83.35% YoY) and the FY2025 annual result came in at $429.5 million, up 47.67% from the prior year.
• Cash & Current Investments advanced to $478.4 million in Q1 2026 per ASTH's latest filing, from $429.5 million in the prior quarter.
• Over five years, Cash & Current Investments peaked at $478.4 million in Q1 2026 and troughed at $217.3 million in Q3 2022.
• A 5-year average of $323.3 million and a median of $296.3 million in 2023 frame the typical range for Cash & Current Investments.
• The sharpest annual moves came in 2022 and 2026: Cash & Current Investments tumbled 34.81% in 2022, then jumped 83.35% in 2026.
• Over 5 years, Cash & Current Investments stood at $293.6 million in 2022, then grew by 0.92% to $296.3 million in 2023, then fell by 1.85% to $290.8 million in 2024, then jumped by 47.67% to $429.5 million in 2025, then climbed by 11.39% to $478.4 million in 2026.
• According to Business Quant data, Cash & Current Investments over the past three periods registered $478.4 million, $429.5 million, and $463.4 million for Q1 2026, Q4 2025, and Q3 2025 respectively.